Keyphrases
Japan
100%
Tumor
41%
Confidence Interval
28%
Schizophrenia
23%
Hepatocellular Carcinoma
23%
Magnetic Resonance Imaging
21%
Moyamoya Disease
21%
Older Men
20%
Risk Factors
20%
Japanese Patients
19%
Chemotherapy
19%
Apoptosis
18%
Computed Tomography
17%
Odds Ratio
16%
Older Women
16%
After Surgery
16%
Type 2 Diabetes Mellitus (T2DM)
15%
Pancreatic Cancer
15%
Clinical Outcomes
15%
Ultrasound
15%
Overall Survival
14%
Monkey
14%
Liver
14%
Induced Apoptosis
13%
Multivariate Analysis
13%
Environment Studies
13%
Child Study
13%
Childrens
13%
Gastric Cancer
13%
Gene Expression
12%
T Cells
12%
Hippocampus
12%
Knock-in Mouse Model
12%
Lung
12%
Left Ventricular Assist Device
11%
No Significant Difference
11%
Platelet-derived Growth factor-BB (PDGF-BB)
11%
N-methyl-D-aspartate Receptor (NMDAR)
11%
Japanese Population
11%
Insulin Resistance
11%
Carbon Ion Radiotherapy
10%
Human Mesenchymal Stem Cells (hMSCs)
10%
Hazard Ratio
10%
Tumor Necrosis Factor-α
10%
Clinical Features
10%
Resection
10%
Elderly Patients
10%
Mouse Model
10%
Adverse Events
10%
Insulin
10%
Overexpression
10%
Prognostic Factors
10%
Global Burden of Disease Study
9%
Phosphorylation
9%
Transcatheter Aortic Valve Replacement
9%
Aneurysm
9%
Metastasis
9%
Inflammation
9%
Hyperthermia
9%
During Pregnancy
9%
Ulcerative Colitis
9%
Amygdala
8%
Heart Failure
8%
Schizophrenic Patients
8%
Patients with Schizophrenia
8%
Ca2+
8%
Tumor Cells
8%
Type 1 Diabetes Mellitus (T1DM)
8%
Central Nervous System
8%
Poor Prognosis
8%
Macrophages
8%
Quantitative PCR
8%
Surgical Treatment
8%
Single-photon Emission Computed Tomography (SPECT)
8%
Patients with Heart Failure
8%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
8%
Obesity
8%
Pancreas
8%
Ossification of the Posterior Longitudinal Ligament
8%
Lung Cancer
8%
Interleukin-6
7%
Quality of Life
7%
Molecular Mechanism
7%
Platelet-derived Growth Factor Receptor (PDGFR)
7%
Young Males
7%
Pancreaticoduodenectomy
7%
Mitogen-activated Protein Kinase
7%
Clinical Characteristics
7%
Heart Rate
7%
Body Mass Index
7%
University Hospital
7%
Randomized Controlled Trial
7%
B Cells
7%
High Risk
7%
Healthy Controls
7%
Cisplatin
7%
Lymph Node Metastasis
7%
Transgenic Mice
7%
Surgical Outcomes
7%
Spinal Cord
7%
Medicine and Dentistry
Neoplasm
65%
Disease
41%
Surgery
38%
Congestive Heart Failure
25%
Recurrent Disease
25%
Magnetic Resonance Imaging
24%
Hepatocellular Carcinoma
24%
Chemotherapy
22%
Malignant Neoplasm
21%
Computer Assisted Tomography
20%
Overall Survival
19%
Left Ventricular Assist Device
18%
Pancreas Cancer
18%
Hemodynamic
17%
Metastatic Carcinoma
17%
Percutaneous Aortic Valve Replacement
16%
Adverse Event
16%
Bleeding
14%
Odds Ratio
14%
Retrospective Study
14%
Abdominal Cancer
13%
Injury
13%
Diagnosis
13%
Aneurysm
13%
Moyamoya Disease
13%
Global Disease Burden
12%
Infection
12%
Prevalence
12%
Multivariate Analysis
12%
Lung
12%
Apoplexy
11%
Prognostic Factor
11%
Cohort Analysis
11%
Lung Cancer
11%
In Vitro
11%
Artery
10%
Biopsy Technique
10%
Radiation Therapy
10%
Hazard Ratio
10%
Survival Rate
10%
Ion Therapy
9%
Programmed Cell Death
9%
Cancer Cell
9%
Hepatectomy
9%
Endoscopic Ultrasound
9%
Messenger RNA
9%
Ossification
9%
Lymphocyte
9%
Adenocarcinoma
9%
Randomized Controlled Trial
9%
Lymph Node Metastasis
9%
Elderly Patient
8%
Cancer
8%
Diabetes Mellitus
8%
Surgical Anastomosis
8%
Prostate Cancer
8%
Brain Ischemia
8%
Maturity Onset Diabetes of the Young
8%
Pediatrics
8%
Pancreaticoduodenectomy
7%
Posterior Longitudinal Ligament
7%
Diabetes
7%
Neck
7%
Combination Therapy
7%
Immunohistochemistry
7%
Biological Marker
7%
Clear Cell Renal Cell Carcinoma
7%
Kampo
7%
Cholestasis
7%
Quality of Life
7%
Surgeon
7%
Stenosis
7%
Postoperative Complication
7%
Carcinoma
7%
Clinical Feature
6%
Atrial Fibrillation
6%
Single-Photon Emission Computed Tomography
6%
Revascularization
6%
Carotid Artery Stenosis
6%
Body Mass Index
6%
Clinical Trial
6%
Mouth Squamous Cell Carcinoma
6%
Morphology
6%
Liver Metastasis
6%
Internal Carotid Artery
6%
Lymph Node
6%
Drug Therapy
6%
Non Small Cell Lung Cancer
6%
Progression Free Survival
6%
Prospective Study
6%
Ulcerative Colitis
6%
Squamous Cell Carcinoma
6%
Pancreas Adenocarcinoma
6%
Lenvatinib
5%
Tumor Cell
5%
Laminoplasty
5%
Transitional Cell Carcinoma
5%
Middle Cerebral Artery
5%
B Cell
5%
Bone Marrow Stromal Cell
5%